Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 29

1.

Yes, Nodal Recurrence of Prostate Cancer is Potentially Curable.

Tendulkar RD, Mian OY.

Int J Radiat Oncol Biol Phys. 2020 Feb 1;106(2):238. doi: 10.1016/j.ijrobp.2019.07.016. No abstract available.

PMID:
31928637
2.

Bladder-sparing treatment of nonmetastatic muscle-invasive bladder cancer.

Ericson KJ, Murthy PB, Bryk DJ, Ramkumar RR, Broughman JR, Khanna A, Mian OY, Campbell SC.

Clin Adv Hematol Oncol. 2019 Dec;17(12):697-707.

PMID:
31851158
3.

Validation of the NCCN prostate cancer favorable- and unfavorable-intermediate risk groups among men treated with I-125 low dose rate brachytherapy monotherapy.

Tom MC, Reddy CA, Smile TD, Zhang RX, Ciezki JP, Stephans KL, Mian OY, Klein EA, Campbell S, Ulchaker J, Angermeier K, Tendulkar RD.

Brachytherapy. 2020 Jan - Feb;19(1):43-50. doi: 10.1016/j.brachy.2019.10.005. Epub 2019 Dec 5.

PMID:
31813740
4.

Validation of a neuroendocrine-like classifier confirms poor outcomes in patients with bladder cancer treated with cisplatin-based neoadjuvant chemotherapy.

Grivas P, Bismar TA, Alva AS, Huang HC, Liu Y, Seiler R, Alimohamed N, Cheng L, Hyndman ME, Dabbas B, Black PC, Davicioni E, Wright JL, Ornstein MC, Mian OY, Kaimakliotis HZ, Gibb EA, Lotan Y.

Urol Oncol. 2019 Dec 4. pii: S1078-1439(19)30459-4. doi: 10.1016/j.urolonc.2019.11.004. [Epub ahead of print]

PMID:
31812633
5.

Analysis of Spatial Dose-Volume Relationships and Decline in Sexual Function Following Permanent Brachytherapy for Prostate Cancer.

Peng LC, Mian OY, Lakshminarayanan P, Huang P, Bae HJ, Robertson S, Habtu T, Narang A, Agarwal S, Greco S, Tran P, McNutt T, DeWeese TL, Song DY.

Urology. 2020 Jan;135:111-116. doi: 10.1016/j.urology.2019.08.014. Epub 2019 Aug 24.

PMID:
31454660
6.

The landscape of early carcinogenesis revealed through the lens of integrative genomics, epigenomics, and transcriptomics.

Balyimez A, Stephans KL, Abazeed ME, Mian OY.

J Thorac Dis. 2019 Jun;11(6):2188-2191. doi: 10.21037/jtd.2019.06.07. No abstract available.

7.

Impact of Cribriform Pattern and Intraductal Carcinoma on Gleason 7 Prostate Cancer Treated with External Beam Radiotherapy.

Tom MC, Nguyen JK, Lucianò R, Mian OY, Stephans KL, Ciezki JP, Smile TD, Wei W, McKenney JK, Magi-Galluzzi C, Tendulkar RD.

J Urol. 2019 Oct;202(4):710-716. doi: 10.1097/JU.0000000000000316. Epub 2019 Sep 6.

PMID:
31059665
8.

Molecular Characterization of Neuroendocrine-like Bladder Cancer.

Batista da Costa J, Gibb EA, Bivalacqua TJ, Liu Y, Oo HZ, Miyamoto DT, Alshalalfa M, Davicioni E, Wright J, Dall'Era MA, Douglas J, Boormans JL, Van der Heijden MS, Wu CL, van Rhijn BWG, Gupta S, Grivas P, Mouw KW, Murugan P, Fazli L, Ra S, Konety BR, Seiler R, Daneshmand S, Mian OY, Efstathiou JA, Lotan Y, Black PC.

Clin Cancer Res. 2019 Jul 1;25(13):3908-3920. doi: 10.1158/1078-0432.CCR-18-3558. Epub 2019 Apr 5.

PMID:
30952638
9.

Correlation between MRI phenotypes and a genomic classifier of prostate cancer: preliminary findings.

Purysko AS, Magi-Galluzzi C, Mian OY, Sittenfeld S, Davicioni E, du Plessis M, Buerki C, Bullen J, Li L, Madabhushi A, Stephenson A, Klein EA.

Eur Radiol. 2019 Sep;29(9):4861-4870. doi: 10.1007/s00330-019-06114-x. Epub 2019 Mar 7.

10.

The ASTRO Research Portfolio: Where Do We Go From Here?

Yu JB, Beck TF, Anscher MS, Baschnagel AM, Brock KK, Carlson DJ, Dominello MM, Kimple RJ, Knisely JPS, Mendonca MS, Mian OY, Singh AK, Moros EG, Keen JC.

Int J Radiat Oncol Biol Phys. 2019 Feb 1;103(2):308-309. doi: 10.1016/j.ijrobp.2018.09.009. No abstract available.

PMID:
30647008
11.

Analysis of the 2017 American Society for Radiation Oncology (ASTRO) Research Portfolio.

Yu JB, Beck TF, Anscher MS, Baschnagel AM, Brock KK, Carlson DJ, Dominello MM, Kimple RJ, Knisely JP, Mendonca MS, Mian OY, Singh AK, Moros EG, Keen JC.

Int J Radiat Oncol Biol Phys. 2019 Feb 1;103(2):297-304. doi: 10.1016/j.ijrobp.2018.07.2056.

PMID:
30647006
12.

Improving prediction of surgical resectability over current staging guidelines in patients with pancreatic cancer who receive stereotactic body radiation therapy.

Cheng Z, Rosati LM, Chen L, Mian OY, Cao Y, Villafania M, Nakatsugawa M, Moore JA, Robertson SP, Jackson J, Hacker-Prietz A, He J, Wolfgang CL, Weiss MJ, Herman JM, Narang AK, McNutt TR.

Adv Radiat Oncol. 2018 Jul 19;3(4):601-610. doi: 10.1016/j.adro.2018.07.002. eCollection 2018 Oct-Dec.

13.

Transcriptomic and Protein Analysis of Small-cell Bladder Cancer (SCBC) Identifies Prognostic Biomarkers and DLL3 as a Relevant Therapeutic Target.

Koshkin VS, Garcia JA, Reynolds J, Elson P, Magi-Galluzzi C, McKenney JK, Isse K, Bishop E, Saunders LR, Balyimez A, Rashid S, Hu M, Stephenson AJ, Fergany AF, Lee BH, Haber GP, Dowlati A, Gilligan T, Ornstein MC, Rini BI, Abazeed ME, Mian OY, Grivas P.

Clin Cancer Res. 2019 Jan 1;25(1):210-221. doi: 10.1158/1078-0432.CCR-18-1278. Epub 2018 Oct 16.

14.

Case study: patient-derived clear cell adenocarcinoma xenograft model longitudinally predicts treatment response.

Vargas R, Gopal P, Kuzmishin GB, DeBernardo R, Koyfman SA, Jha BK, Mian OY, Scott J, Adams DJ, Peacock CD, Abazeed ME.

NPJ Precis Oncol. 2018 Jul 11;2:14. doi: 10.1038/s41698-018-0060-3. eCollection 2018.

15.

The evolving role of molecular profiling in prostate cancer: basal and luminal subtyping transcends tissue of origin.

Mian OY, Tendulkar RD, Abazeed ME.

Transl Cancer Res. 2017 Dec;6(Suppl 9):S1441-S1445. doi: 10.21037/tcr.2017.10.49. No abstract available.

16.

Intraoperative Registered Ultrasound and Fluoroscopy (iRUF) for dose calculation during prostate brachytherapy: Improved accuracy compared to standard ultrasound-based dosimetry.

Lee J, Mian OY, Le Y, Bae HJ, Burdette EC, DeWeese TL, Prince JL, Song DY.

Radiother Oncol. 2017 Jul;124(1):61-67. doi: 10.1016/j.radonc.2017.05.018. Epub 2017 Jun 21.

17.

Computed tomography imaging assessment of postexternal beam radiation changes of the liver.

Lock M, Malayeri AA, Mian OY, Mayr NA, Herman JM, Lo SS.

Future Oncol. 2016 Dec;12(23):2729-2739. Epub 2016 Aug 31. Review.

18.

Timely stereotactic body radiotherapy (SBRT) for spine metastases using a rapidly deployable automated planning algorithm.

Mian OY, Thomas O, Lee JJ, Le Y, McNutt T, Lim M, Rigamonti D, Wolinsky JP, Sciubba DM, Gokaslan ZL, Redmond K, Kleinberg L.

Springerplus. 2016 Aug 11;5(1):1337. doi: 10.1186/s40064-016-2961-3. eCollection 2016.

19.

Prevalence of Substance Use in Patients With Cancer Receiving Radiation Therapy.

Choflet A, Narang AK, Herald Hoofring L, Bonerigo S, Mian OY, Katulis L, Cheng Z, Appling S.

Clin J Oncol Nurs. 2016 Aug 1;20(4):397-402. doi: 10.1188/16.CJON.397-402.

PMID:
27441512
20.

GSTP1 Loss results in accumulation of oxidative DNA base damage and promotes prostate cancer cell survival following exposure to protracted oxidative stress.

Mian OY, Khattab MH, Hedayati M, Coulter J, Abubaker-Sharif B, Schwaninger JM, Veeraswamy RK, Brooks JD, Hopkins L, Shinohara DB, Cornblatt B, Nelson WG, Yegnasubramanian S, DeWeese TL.

Prostate. 2016 Feb;76(2):199-206. doi: 10.1002/pros.23111. Epub 2015 Oct 8.

21.

An image-guidance system for dynamic dose calculation in prostate brachytherapy using ultrasound and fluoroscopy.

Kuo N, Dehghan E, Deguet A, Mian OY, Le Y, Burdette EC, Fichtinger G, Prince JL, Song DY, Lee J.

Med Phys. 2014 Sep;41(9):091712. doi: 10.1118/1.4893761.

22.

Management options in locally advanced pancreatic cancer.

Mian OY, Ram AN, Tuli R, Herman JM.

Curr Oncol Rep. 2014 Jun;16(6):388. doi: 10.1007/s11912-014-0388-y. Review.

PMID:
24740136
23.

Methyl-binding domain protein 2-dependent proliferation and survival of breast cancer cells.

Mian OY, Wang SZ, Zhu SZ, Gnanapragasam MN, Graham L, Bear HD, Ginder GD.

Mol Cancer Res. 2011 Aug;9(8):1152-62. doi: 10.1158/1541-7786.MCR-11-0252. Epub 2011 Jun 21.

24.

The role of the epigenetic signal, DNA methylation, in gene regulation during erythroid development.

Ginder GD, Gnanapragasam MN, Mian OY.

Curr Top Dev Biol. 2008;82:85-116. doi: 10.1016/S0070-2153(07)00004-X. Review.

PMID:
18282518
25.

Atherosclerotic plaque macrophage transcriptional regulators are expressed in blood and modulated by tristetraprolin.

Patino WD, Kang JG, Matoba S, Mian OY, Gochuico BR, Hwang PM.

Circ Res. 2006 May 26;98(10):1282-9. Epub 2006 Apr 13.

PMID:
16614304
26.

Targeted disruption of p53 attenuates doxorubicin-induced cardiac toxicity in mice.

Shizukuda Y, Matoba S, Mian OY, Nguyen T, Hwang PM.

Mol Cell Biochem. 2005 May;273(1-2):25-32.

PMID:
16013437
27.

Circulating transcriptome reveals markers of atherosclerosis.

Patino WD, Mian OY, Kang JG, Matoba S, Bartlett LD, Holbrook B, Trout HH 3rd, Kozloff L, Hwang PM.

Proc Natl Acad Sci U S A. 2005 Mar 1;102(9):3423-8. Epub 2005 Feb 22.

28.

Current and future applications of SAGE to cardiovascular medicine.

Patino WD, Mian OY, Shizukuda Y, Hwang PM.

Trends Cardiovasc Med. 2003 May;13(4):163-8. Review.

PMID:
12732451
29.

Serial analysis of gene expression: technical considerations and applications to cardiovascular biology.

Patino WD, Mian OY, Hwang PM.

Circ Res. 2002 Oct 4;91(7):565-9. Review.

PMID:
12364383

Supplemental Content

Support Center